Neuronal intracellular transport and neurodegenerative disease

Neurology

Volumn 76, Issue 11, 2011, Pages 1015-1020

  Staff, Nathan P ^a   Benarroch, Eduardo E ^a   Klein, Christopher J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ALPHA TUBULIN; BETA TUBULIN; KINESIN; MOLECULAR MOTOR;

ARTICLE; CYTOSKELETON; DEGENERATIVE DISEASE; GENE MUTATION; HUMAN; INTRACELLULAR TRANSPORT; MICROTUBULE; NERVE CELL; NEURITE; NEURONAL INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

EID: 79953210409     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31821103f7     Document Type: Article

References (47)

1. Ramon y Cajal S. New Ideas on the Structure of the Nervous System in Man and Vertebrates. Cambridge, MA: MIT Press; 1990.
2. De Vos KJ, Grierson AJ, Ackerley S, Miller CC. Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 2008;31:151-173.
3. Morfini GA, Burns M, Binder LI, et al. Axonal transport defects in neurodegenerative diseases. J Neurosci 2009;29: 12776-12786.
4. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Biology of the Cell, 5th ed. New York, NY: Garland Science; 2008.
5. Hirokawa N, Noda Y. Intracellular transport and kinesin superfamily proteins, KIFs: structure, function, and dynamics. Physiol Rev 2008;88:1089-1118.
6. Brown A. Axonal transport of membranous and nonmembranous cargoes: a unified perspective. J Cell Biol 2003; 160:817-821. (Pubitemid 36350837)
7. Goldstein AY, Wang X, Schwarz TL. Axonal transport and the delivery of pre-synaptic components. Curr Opin Neurobiol 2008;18:495-503.
8. Saotome M, Safiulina D, Szabadkai G, et al. Bidirectional Ca2-dependent control of mitochondrial dynamics by the Miro GTPase. Proc Natl Acad Sci USA 2008;105: 20728-20733.
9. Levy JR, Holzbaur EL. Cytoplasmic dynein/dynactin function and dysfunction in motor neurons. Int J Dev Neurosci 2006;24:103-111. (Pubitemid 43294616)
10. Brown ME, Bridgman PC. Myosin function in nervous and sensory systems. J Neurobiol 2004;58:118-130. (Pubitemid 37543343)
11. Singh KK, Tsai LH. MicroTUB(B3)ules and brain development. Cell 2010;140:30-32.
12. Brimijoin S. Axonal transport: properties, mechanisms, and role in nerve disease. In: Dyck PJ, Thomas PK, eds. Peripheral Neuropathy, 4th ed. Philadelphia, PA: Elsevier Saunders; 2005:2553-2583.
13. Herskovitz S, Schaumburg HH. Neuropathy caused by drugs. In: Dyck PJ, Thomas PK, eds. Peripheral Neuropathy, 4th ed. Philadelphia, PA: Elsevier Saunders; 2005: 2553-2583.
14. Reid E, Kloos M, Ashley-Koch A, et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 2002;71:1189-1194. (Pubitemid 35305237)
15. Goizet C, Boukhris A, Mundwiller E, et al. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat 2009;30:E376-385.
16. Ebbing B, Mann K, Starosta A, et al. Effect of spastic paraplegia mutations in KIF5A kinesin on transport activity. Hum Mol Genet 2008;17:1245-1252. (Pubitemid 351566961)
17. Zhao C, Takita J, Tanaka Y, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 2001;105:587-597. (Pubitemid 32524112)
18. Puls I, Jonnakuty C, LaMonte BH, et al. Mutant dynactin in motor neuron disease. Nat Genet 2003;33:455-456. (Pubitemid 36390002)
19. Farrer MJ, Hulihan MM, Kachergus JM, et al. DCTN1 mutations in Perry syndrome. Nat Genet 2009;41:163-165.
20. Tischfield MA, Baris HN, Wu C, et al. Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. Cell 2010;140:74-87.
21. LaPointe NE, Morfini G, Pigino G, et al. The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. J Neurosci Res 2009;87: 440-451.
22. Pigino G, Morfini G, Atagi Y, et al. Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proc Natl Acad Sci USA 2009;106: 5907-5912.
23. Morfini GA, You YM, Pollema SL, et al. Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat Neurosci 2009;12:864-871.
24. Gauthier LR, Charrin BC, Borrell-Pages M, et al. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 2004;118:127-138. (Pubitemid 38902819)
25. Dompierre JP, Godin JD, Charrin BC, et al. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J Neurosci 2007;27:3571-3583. (Pubitemid 46515140)
26. Saha AR, Hill J, Utton MA, et al. Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons. J Cell Sci 2004;117:1017-1024. (Pubitemid 38456084)
27. Morfini G, Pigino G, Opalach K, et al. 1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C. Proc Natl Acad Sci USA 2007;104:2442-2447. (Pubitemid 46391416)
28. Warita H, Itoyama Y, Abe K. Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene. Brain Res 1999;819:120-131. (Pubitemid 29225463)
29. Williamson TL, Cleveland DW. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 1999;2: 50-56. (Pubitemid 30488940)
30. Ackerley S, Grierson AJ, Banner S, et al. p38alpha stressactivated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol Cell Neurosci 2004;26:354-364. (Pubitemid 38781091)
31. De Vos KJ, Chapman AL, Tennant ME, et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum Mol Genet 2007;16:2720-2728. (Pubitemid 350018514)
32. Ackerley S, Grierson AJ, Brownlees J, et al. Glutamate slows axonal transport of neurofilaments in transfected neurons. J Cell Biol 2000;150:165-176.
33. Stevenson A, Yates DM, Manser C, et al. Riluzole protects against glutamate-induced slowing of neurofilament axonal transport. Neurosci Lett 2009;454:161-164.
34. Ermolayev V, Friedrich M, Nozadze R, et al. Ultramicroscopy reveals axonal transport impairments in cortical motor neurons at prion disease. Biophys J 2009;96:3390-3398.
35. Salinas S, Proukakis C, Crosby A, Warner TT. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol 2008;7:1127-1138.
36. Solowska JM, Morfini G, Falnikar A, et al. Quantitative and functional analyses of spastin in the nervous system: implications for hereditary spastic paraplegia. J Neurosci 2008;28:2147-2157. (Pubitemid 351317638)
37. Evgrafov OV, Mersiyanova I, Irobi J, et al. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 2004;36:602-606. (Pubitemid 38715987)
38. Irobi J, Van Impe K, Seeman P, et al. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet 2004;36:597-601. (Pubitemid 38715986)
39. Kolb SJ, Snyder PJ, Poi EJ, et al. Mutant small heat shock protein B3 causes motor neuropathy: utility of a candidate gene approach. Neurology 2010;74:502-506.
40. Cleveland DW, Yamanaka K, Bomont P. Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway. Hum Mol Genet 2009;18:1384-1394.
41. Allen E, Ding J, Wang W, et al. Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival. Nature 2005;438:224-228. (Pubitemid 41599874)
42. Deinhardt K, Salinas S, Verastegui C, et al. Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron 2006;52:293-305. (Pubitemid 44548343)
43. Perez-Olle R, Lopez-Toledano MA, Goryunov D, et al. Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport. J Neurochem 2005;93:861-874. (Pubitemid 40695745)
44. De Waegh SM, Lee VM, Brady ST. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 1992; 68:451-463.
45. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006;443: 787-795. (Pubitemid 44622683)
46. Misko A, Jiang S, Wegorzewska I, Milbrandt J, Baloh RH. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci 2010;30:4232-4240.
47. Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science 2008;319: 916-919. (Pubitemid 351263754)